Prodigiosin from Serratia Marcescens in Cockroach Inhibits the Proliferation of Hepatocellular Carcinoma Cells

Jie Wang1,2, Hancong Liu1,2, Liuchong Zhu1,2

  • 1School of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510000, China.

Insights

Prodigiosin (PG) from Serratia marcescens induces endoplasmic reticulum stress (ERS)-mediated apoptosis in liver cancer cells. This natural compound inhibits hepatocellular carcinoma (HCC) growth without harming major organs in mice.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent liver cancer with limited targeted therapies.
  • Prodigiosin (PG), a metabolite from Serratia marcescens, previously showed potential in inhibiting HCC proliferation.
  • The precise mechanisms of PG's action in liver cancer, particularly regarding endoplasmic reticulum stress (ERS), require elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which PG induces ERS and apoptosis in liver cancer cells.
  • To evaluate the efficacy and safety of PG in both in vitro and in vivo models of HCC.

Main Methods:

  • Utilized flow cytometry, colony formation assays, cell viability assays, immunoblot analysis, and TUNEL assays to assess apoptosis and proliferation.
  • Employed laser confocal fluorescence microscopy for PG localization within cells.
  • Measured intracellular Ca2+ concentration and analyzed the expression of key ERS and apoptotic proteins (PERK, IRE1α, Bip, CHOP, caspase3, caspase9, Bax, Bcl-2).

Main Results:

  • PG was localized in the endoplasmic reticulum of HepG2 cells, inducing Ca2+ release and promoting apoptosis.
  • PG upregulated pro-apoptotic proteins (caspase3, caspase9, Bax) and ERS markers (PERK, IRE1α, Bip, CHOP) while downregulating anti-apoptotic Bcl-2.
  • In vivo studies in nude mice showed PG inhibited HCC growth by inducing ERS, with no significant adverse effects on major organs.

Conclusions:

  • Prodigiosin effectively promotes apoptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress.
  • PG demonstrates therapeutic potential for HCC, acting through ERS pathways and exhibiting a favorable safety profile in preclinical models.